HIV Treatment Reduces Accelerated Biological Aging by Nearly Four Years, Landmark Study Shows

HIV treatment reduces accelerated biological aging by nearly four years, landmark study shows

A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological aging in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor HIV treatment and long-term health outcomes.

Landmark Study Finds HIV Treatment Slows Biological Aging by Nearly Four

A groundbreaking study unveiled at ESCMID Global 2026 in Munich has revealed that antiretroviral therapy (ART) has a profound impact on reducing the accelerated biological ageing associated with HIV infection. Researchers have demonstrated that, in people living with HIV (PWH), ART can reverse accelerated biological ageing by nearly four years, a discovery poised to revolutionize both clinical monitoring and long-term management of HIV. The stud…